Alignment Healthcare Inc
Health Care
Alignment Healthcare Inc (ALHC) Stock News
The latest ALHC headlines and market coverage — 10 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) and Certain of its Officers and Directors for Potential Securities Law Violations
Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) for potential securities violations following a whistleblower complaint alleging accounting irregularities and misclassification of operating expenses as capital expenditures. The allegations artificially inflated the company's financial results and Adjusted EBITDA metrics. ALHC stock fell 16.7% on July 8, 2026, following the news.
- GlobeNewswire Inc.·
Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Violations of the Federal Securities Laws
Law firm Lowey Dannenberg is investigating Alignment Healthcare (ALHC) for potential federal securities violations following allegations by a former executive that the company manipulated finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The disclosure caused Alignment's stock to fall 16.7% on July 8, 2026.
- GlobeNewswire Inc.·
Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About the Investigation of Potential Securities Law Violations
Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) following a whistleblower complaint alleging accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.
- GlobeNewswire Inc.·
ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation
Hagens Berman is investigating Alignment Healthcare, Inc. (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to artificially inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.
- GlobeNewswire Inc.·
Kaplan Fox Reminds Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm Regarding an Investigation of Potential Securities Law Violations
Law firm Kaplan Fox is investigating Alignment Healthcare for alleged accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the whistleblower complaint disclosure.
- GlobeNewswire Inc.·
ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation
Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to inflate EBITDA and financial results for 2024-2025. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.
- GlobeNewswire Inc.·
ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation
Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities, misclassifying operating expenses as capital expenditures to inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.
- GlobeNewswire Inc.·
ALHC ALERT: Block & Leviton Investigating Alignment Healthcare, Inc. For Possible Securities Fraud; Investors Should Contact Block & Leviton to Learn More
Block & Leviton is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances to boost stock price and executive compensation. The stock fell approximately 16.72% following the report. The firm is also investigating Jefferies Financial Group and Unicycive Therapeutics for similar violations.
- GlobeNewswire Inc.·
ALHC Investor Notice: Johnson Fistel Investigates Alignment Healthcare, Inc.
Law firm Johnson Fistel announced an investigation into Alignment Healthcare (NASDAQ: ALHC) following a whistleblower lawsuit filed by a former executive alleging the company manipulated its finances to boost stock price and executive compensation. The firm is investigating whether the company complied with federal securities laws and is seeking investors who suffered losses.
- The Motley Fool·
Vice Chairman of Alignment Healthcare Sells 25,000 Shares. Does This Mean Sell ALHC?
Joseph Konowiecki, vice chairman of Alignment Healthcare, sold 25,000 shares on June 26 for $575,000, reducing his direct holdings by 2.2%. While the sale aligns with his historical trading pattern and occurs under a pre-filed trading plan, the timing coincides with his recent step down from chairman and follows a pattern of executive selling over the past year. However, insider sales are predictive of stock declines less than half the time, and investors should weigh this against other company fundamentals.